Generic
Coport L 10/5mg contains the active ingredients Empagliflozin (10mg) and Linagliptin (5mg).
Description
Coport L 10/5mg is a prescription tablet combining Empagliflozin and Linagliptin, two antidiabetic agents used to improve glycemic control in adults with type 2 diabetes. It helps to reduce blood glucose levels by inhibiting glucose reabsorption and increasing insulin production.
Benefits
- Helps regulate blood sugar levels in type 2 diabetes patients
- Reduces the risk of cardiovascular complications
- Increases urinary glucose excretion
- Can be used in patients with metformin intolerance
Ingredients
Empagliflozin 10mg
Linagliptin 5mg
Uses and Doses
Coport L 10/5mg is used to treat type 2 diabetes mellitus. The recommended dose is one tablet taken once daily, with or without food. In cases of combination with insulin, a reduced dose may be necessary to avoid hypoglycemia.
Side Effects
Common side effects include hypoglycemia, pancreatitis, genital infections, urinary tract infections, and elevated LDL cholesterol levels.
How to Use
Take one tablet daily as prescribed, with or without food. If a dose is missed, take it as soon as you remember. Do not double doses.
Pregnancy & Lactation
The use of Linagliptin and Empagliflozin has not been studied in pregnant women, so it should be avoided unless necessary. Breastfeeding mothers should discontinue the medication or consider alternative treatment.
Precautions and Warnings
- Monitor for signs of pancreatitis, hypoglycemia, or urinary tract infections
- Assess renal function regularly
- Consider adjusting insulin doses to avoid hypoglycemia
- Avoid use during pregnancy or while breastfeeding
Safety Information
Use only under medical supervision. Keep out of reach of children. Store below 30°C in a dry place away from direct sunlight.
Indications
Indicated for type 2 diabetes mellitus in adults to improve glycemic control when other treatments are insufficient.
Pharmacology
Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor, promoting glucose excretion via urine. Linagliptin inhibits DPP-4 enzymes, which enhances insulin release and decreases glucagon levels.
Therapeutic Class
Antidiabetic agent
Storage Conditions
Store in a cool, dry place below 30°C, protected from light and moisture. Keep out of the reach of children.
3 FAQ
- Can I take Coport L 10/5mg with other diabetes medications?
Yes, but consult your doctor for dosage adjustments if using insulin or sulfonylureas. - What should I do if I miss a dose?
Take it as soon as you remember, but avoid double doses. - Are there any dietary restrictions while using this medication?
There are no specific dietary restrictions, but maintaining a healthy diet helps in managing diabetes.
Disclaimer
Always consult your healthcare provider to ensure the information displayed on this page applies to your circumstances. This medication should be taken only under medical supervision.
Keywords: Coport L, type 2 diabetes treatment, empagliflozin 10mg, linagliptin 5mg, ACI Limited, SGLT2 inhibitor, DPP-4 inhibitor, blood sugar control, diabetes medication, glycemic control, renal protection, hypoglycemia risk, pancreatitis monitoring, urinary glucose excretion, insulin sensitivity, antidiabetic drug, combination therapy, diabetic tablets, metformin intolerance, prescription drugs, diabetes care.
Additional information
Weight | 0.05 kg |
---|---|
Dimensions | 4.5 × 2 × 0.5 in |
Class -Dosage | Tablets |
Size | (10mg+5mg) |
Generics | Empagliflozin+Linagliptin |
pharmaceuticals | ACI Limited |
Reviews
There are no reviews yet.